Assess the Efficacy and Safety of Personalized Prophylaxis Human-cl rhFVIII in Patients With Severe Haemophilia A

NCT02256917 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
58
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Octapharma